维普期刊资源整合服务平台（V6.5）

124篇 您的检索式：作者名="KRALOVICS R"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	A Gain of Function Mutation of JAK2 in Myeloproliferative Disorders显示文摘	Kralovics R Passamonti F Buser A S	2005	N Engl J Med2005，352，17：	1
2	A gain of function mutation of JAK2 in myeloproliferative disorders显示文摘	KRALOVICS R PASSAMONTI F BUSER A S	2005	N Engl J Med2005，352，：	1
3	A gain-of-func?tion mutation ofJ AK2 in myeloproliferative disorders显示文摘	Kralovics R Passamonti F Buser A S ct al	2005	N EnglJ Med2005，352，17：	1
4	A gain of function mutation of JAK2 in myeloproliferative disorders显示文摘	Kralovics R Passamonti F BuserAS		0，，：	1
5	The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera显示文摘	BOISSINOT M KRALOVICS R	2006	Blood2006，108，：	1
6	A gain-of-function mutation of JAK2in myelopro-liferative disorders显示文摘	KRALOVICS R PASSAMONTI F BUSER A S	2005	N Engl J Med2005，352，：	1
7	A gain-of-function mutation of JAK2 in myeloproliferative disorders 显示文摘	KRALOVICS R PASSAMONTI F BUSERS S A	2005	N Med2005，352，：	1
8	A gain-of-function mutation of JAK2 in myeloproliferative disorders 显示文摘	Kralovics R Passamonti F Buser AS	2005	N Engl J Med2005，352，：	1
9	A gain-of-function mutation of JAK2 in myeloproliferative disorders 显示文摘	KRALOVICS R PASSAMONTI F BUSERS S A	2005	N Engl J Med2005，352，：	1
10	Veterans Affairsinitiative to prevent methicillin-resistant Staphylococcusaureus infections显示文摘	Jain R Kralovic SM Evans ME	2011	N Engl J Med2011，364，15：	1
11	Again of function mutation in JAK2is frequently foundingatients with myeloprofiferative disorders显示文摘	KRALOVICS R PASSAMONTI F BUSER A S	2005	N Engl J Med2005，352，：	1
12	Organization of telomeric and subtelomeric chromatin in the higher plant Nicotiana tabacum显示文摘	Fajkus J Kovarik A Kralovics R	1995	Molecular and General Genetics1995，247，：	1
13	Again - of - function mutation of JAK2 in myelopmliferative disorders 显示文摘	Kralovics R Passamonti F Buser AS	2005	N Engl J Med2005，352，：	1
14	A gain-of-function mutation of JAK2 in myeloproliferative disorders 显示文摘	Kralovics R Passamonti F Buser AS	2005	N Engl J Med2005，352，17：	1
15	The JAK2V617F mutation is frequently p resent at diagnosis in patients with essential thrombocythemiaand polycythemia vera显示文摘	Lippert E Boissinot M Kralovics R		0，，：	1
16	A gain-of-function mutation of JAK2 in myeloproliferative disorders显示文摘	Kralovics R Passamonti F Buser A	2005	N Engl J Med2005，352，17：	1
17	A gain-of-function mutation of JAK2 in myeloproliferative disorders 显示文摘	Kralovics R Passamonti F Buser AS	2005	N Engl J Med2005，352，17：	1
18	The JAK2-V617F mutation is freguently present at diagnosis in patients with essential thrombocy themia and polycythemia vera显示文摘	Lippert E Boissinot M Kralovics R	2006	Blood2006，108，6：	1
19	The JAK2-V617F mutation is frequently present at diagnosis in patients withessential thrombocythemia and polyeythemia vera显示文摘	LIPPERT E BOISSINOT M KRALOVICS R	2006	Blood2006，108，：	1
20	From Janus kinase 2 to calreticulin : the clinically relevant genomic landscape of myeloproliferative neoplasms 显示文摘	Cazzola M Kralovics R	2014	Blood2014，123，24：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示